AIM: To investigate the long-term effects of central fat mass (CFM) and peripheral fat mass (PFM) on atherogenic risk profile and the progression of aortic calcification (AC) in postmenopausal women. METHODS AND RESULTS: Participants were 316 women aged 50-76 years, who were followed for 7.7 years. CFM and PFM were measured at baseline by DXA and related to follow-up measures of atherogenic metabolites, blood pressure, and the progression of AC assessed on lateral radiographs. CFM and PFM independently of each other exhibited contrasting influence on follow-up measures of atherogenic risk factors and the progression of AC. In a multiple regression model, the negative contribution of PFM (P<0.05), but not the adverse contribution of CFM, was independent of confounders. When comparing different extreme forms of obesity, women with central obesity showed the greatest (2.36+/-0.60, n=11), whereas those with peripheral obesity the smallest changes in AC (0.50+/-0.34, n=10) over the study period. Women with general obesity also tended to show less progression of AC compared with women with central obesity (1.23+/-0.42, n=21). CONCLUSIONS: This study provides direct support for the independent anti-atherogenic influence of PFM and calls on further research to define the adipocyte-derived factors involved in this favourable effect.
AIM: To investigate the long-term effects of central fat mass (CFM) and peripheral fat mass (PFM) on atherogenic risk profile and the progression of aortic calcification (AC) in postmenopausal women. METHODS AND RESULTS:Participants were 316 women aged 50-76 years, who were followed for 7.7 years. CFM and PFM were measured at baseline by DXA and related to follow-up measures of atherogenic metabolites, blood pressure, and the progression of AC assessed on lateral radiographs. CFM and PFM independently of each other exhibited contrasting influence on follow-up measures of atherogenic risk factors and the progression of AC. In a multiple regression model, the negative contribution of PFM (P<0.05), but not the adverse contribution of CFM, was independent of confounders. When comparing different extreme forms of obesity, women with central obesity showed the greatest (2.36+/-0.60, n=11), whereas those with peripheral obesity the smallest changes in AC (0.50+/-0.34, n=10) over the study period. Women with general obesity also tended to show less progression of AC compared with women with central obesity (1.23+/-0.42, n=21). CONCLUSIONS: This study provides direct support for the independent anti-atherogenic influence of PFM and calls on further research to define the adipocyte-derived factors involved in this favourable effect.
Authors: M Sánchez-López; F B Ortega; P Moya-Martínez; S López-Martínez; I Ortiz-Galeano; M A Gómez-Marcos; M Sjöström; V Martínez-Vizcaíno Journal: Eur J Nutr Date: 2012-04-07 Impact factor: 5.614
Authors: Xianwen Shang; David Scott; Allison Hodge; Belal Khan; Nayab Khan; Dallas R English; Graham G Giles; Peter R Ebeling; Kerrie M Sanders Journal: Int J Cardiovasc Imaging Date: 2016-05-31 Impact factor: 2.357
Authors: Caroline S Fox; Shih-Jen Hwang; Joseph M Massaro; Kathrin Lieb; Ramachandran S Vasan; Christopher J O'Donnell; Udo Hoffmann Journal: Am J Cardiol Date: 2009-06-24 Impact factor: 2.778
Authors: Mahasampath Gowri S; Belavendra Antonisamy; Finney S Geethanjali; Nihal Thomas; Felix Jebasingh; Thomas V Paul; Fredrik Karpe; Clive Osmond; Caroline H D Fall; Senthil K Vasan Journal: Int J Obes (Lond) Date: 2021-07-30 Impact factor: 5.095